Context Therapeutics Inc.
CNTX
$1.09
$0.032.83%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.31% | -84.24% | -29.60% | -11.52% | -45.30% |
| Total Depreciation and Amortization | 43.40% | 27.52% | 7.83% | -9.92% | -16.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.41% | 1,644.44% | 1,376.68% | 1,284.85% | 1,273.45% |
| Change in Net Operating Assets | 215.43% | 167.77% | -683.30% | -295.76% | -228.00% |
| Cash from Operations | -32.42% | 3.81% | 22.64% | 30.84% | 4.92% |
| Capital Expenditure | -364.38% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 99.77% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.67% | -84.67% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -84.68% | -84.73% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.46% | -123.59% | 502.76% | 479.99% | 455.63% |